Bio Medical & Healthcare

Supporting biomedical and healthcare companies to navigate and enter Asia’s rapidly expanding healthcare markets

Asia Market Opportunity

Asia’s healthcare market is projected to reach USD 4 trillion by 2030, driven by ageing populations, rising incomes, and increasing chronic disease burden across the region
Southeast Asia’s biomedical and pharmaceutical market is growing at over 8% annually, with Indonesia, Vietnam, and the Philippines among the fastest-growing markets
Medical device and diagnostics demand is surging across ASEAN, supported by government hospital infrastructure investment and expanding private healthcare networks
Healthcare digitalisation — telemedicine, health technology, and hospital information systems — is accelerating rapidly across Asia post-pandemic

Market entry strategy for pharmaceutical, biomedical, medical device, and healthcare technology companies
Regulatory pathway analysis — ASEAN harmonisation frameworks, BPOM (Indonesia), HSA (Singapore), FDA (Philippines), and other national regulators
Distributor and partner identification across pharmaceutical wholesale, hospital procurement, and retail pharmacy channels
Market research on disease burden, healthcare infrastructure, pricing, and reimbursement frameworks
Investment feasibility studies for hospital, clinic, and healthcare facility development across ASEAN
Trade mission support for UK biomedical and healthcare companies exploring Asian markets

Japanese Bio Medical Device Manufacturer — Market Analysis for Malaria Blood Testing Equipment — India, Indonesia, Thailand

Identified market potential in rural and urban areas; enabled client to prioritise entry markets

European In Vitro Diagnostics (IVD) Manufacturer — Market Study & B2B Buyer Search — Indonesia, Malaysia

Identified regulatory barriers and generated 10 qualified B2B buyer company leads

Singapore · Indonesia · Malaysia · Vietnam · Philippines · Thailand · Myanmar · India · China · Bangladesh

Speak with our consultants about your biomedical and healthcare market entry strategy.